Migdal Insurance & Financial Holdings Ltd. Bio N Tech Se Transaction History
Migdal Insurance & Financial Holdings Ltd.
- $6.18 Billion
- Q3 2024
A detailed history of Migdal Insurance & Financial Holdings Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Migdal Insurance & Financial Holdings Ltd. holds 605 shares of BNTX stock, worth $69,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
605
Previous 605
-0.0%
Holding current value
$69,677
Previous $49,000
46.94%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$957 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$520 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$502 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$218 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$208 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...